Shares of Henry Schein Inc. HSIC shed 0.77% to $70.42 Friday, on what proved to be an all-around poor trading session for the ...

Henry Schein Inc. closed $11.66 short of its 52-week high ($82.63), which the company achieved on February 27th.

Henry Schein, Inc.’s HSIC joint venture, Henry Schein One, is driving strong growth in its core products and introducing new solutions. The company’s robust acquisition strategy helps it to pursue ...

Henry Schein is a leading global distributor of health-care products and services primarily to office-based dental and medical practitioners. The company operates through two segments that offer ...

Henry Schein provided an updated financial outlook for 2024. The company expects adjusted EPS to be in the range of $4.74-$4.82 (previously $4.70-$4.82). The revised figure reflects 5-7% growth ...

Henry Schein's HSIC short percent of float has risen 3.96% since its last report. The company recently reported that it has 6 ...

Henry Schein (NASDAQ:HSIC) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ...

Through its 26th annual “Holiday Cheer” program, Henry Schein team members at 15 company locations delivered joy to more than ...

Henry Schein is a candidate surfaced by a screen in this sector. It has many characteristics that I like in companies: easy-to-understand business, and profitable, among many others. There are ...

Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Petusky from Barrington maintained a Buy rating on the stock ...

Henry Schein, Inc.’s HSIC joint venture, Henry Schein One, is driving strong growth in its core products and introducing new solutions. The company’s robust acquisition strategy helps it to ...